A recent update on the antibacterial effects of distinct bioactive molecules derived from the Cannabis plant
European Journal of Microbiology and Immunology · 18.12.2024 · 14 (4) · 333-339
DOI: 10.1556/1886.2024.00098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Microbiology and Immunology, erschienen am 18.12.2024. Verfasst von Mathis Werner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, Infectious Diseases and Immunology, Gastrointestinal Microbiology Research Group, Charité - University Medicine Berlin, Co…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The number of human infections with multidrug-resistant (MDR) bacteria is increasing worldwide and constitutes a serious threat to human health. Given the lack of novel antibiotic compounds worsening this dilemma, alternative antibiotic-independent treatment and prevention strategies of infectious diseases applying natural compounds appear highly appreciable. Given the long-known health-beneficial and disease-alleviating properties of Cannabis , we performed a literature search summarizing current knowledge regarding the antibacterial effects of extracts from different parts of the Cannabis sativa plant and of defined Cannabis -derived molecules and their potential mode of action. The included studies revealed that various extracts and essential oils of C . sativa as well as major cannabinoids exerted potent activities against a broad spectrum of Gram-positive bacteria and against some Gram-negative bacterial species including MDR strains. Particularly the disruption of the bacterial cytoplasmic membrane by some cannabinoids resulted in potent antibacterial effects against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus . Furthermore, defined cannabinoids inhibited the formation of and eradicated existing bacterial biofilms. In conclusion, given their antibacterial properties distinct Cannabis -derived molecules expand the repertoire of antibiotics-independent treatment options in the combat of bacterial infectious diseases which should be further addressed in future studies including clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Microbiology, Infectious Diseases and Immunology, Gastrointestinal Microbiology Research Group, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Be…
ORCID-Profile: Markus M Heimesaat
Zitieren
APA
Werner, M., Bereswill, S., & Heimesaat, M. M. (2024). A recent update on the antibacterial effects of distinct bioactive molecules derived from the Cannabis plant. European Journal of Microbiology and Immunology, 14(4), 333-339. https://doi.org/10.1556/1886.2024.00098
Vancouver
Werner M, Bereswill S, Heimesaat MM. A recent update on the antibacterial effects of distinct bioactive molecules derived from the Cannabis plant. European Journal of Microbiology and Immunology. 2024;14(4):333-339. doi:10.1556/1886.2024.00098
BibTeX
@article{Werner2024,
author = {Werner, Mathis and Bereswill, Stefan and Heimesaat, Markus M},
title = {A recent update on the antibacterial effects of distinct bioactive molecules derived from the Cannabis plant},
journal = {European Journal of Microbiology and Immunology},
year = {2024},
volume = {14},
number = {4},
pages = {333--339},
doi = {10.1556/1886.2024.00098}
}
EUVIMED